Fatal pulmonary toxicity in testis cancer with bleomycin-containing chemotherapy

Journal of Clinical Oncology

Volumn 25, Issue 23, 2007, Pages 3543-3544

  Keijzer, Anita ^a   Kuenen, Bart ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CISPLATIN; CORTICOSTEROID; ETOPOSIDE;

ADULT; ANAMNESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYANOSIS; DRUG ACTIVITY; DRUG ELIMINATION; DRUG FATALITY; DRUG MEGADOSE; DYSPNEA; FEVER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; LUNG FUNCTION TEST; LUNG TOXICITY; MALE; PHYSICAL EXAMINATION; PNEUMOMEDIASTINUM; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; SUBCUTANEOUS EMPHYSEMA; TACHYCARDIA; TESTIS CANCER; THORAX RADIOGRAPHY;

ADULT; ANTINEOPLASTIC AGENTS; BLEOMYCIN; FATAL OUTCOME; HUMANS; LUNG DISEASES; MALE; MEDIASTINAL EMPHYSEMA; RADIOGRAPHY, THORACIC; TESTICULAR NEOPLASMS;

EID: 34548185939     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.2218     Document Type: Article

References (10)

1. Azumbuja E, Fleck JF, Batista RG, et al: Bleomycin lung toxicity: Who are the patients with increased risk? Pulm Pharmacol Ther 18:363-366, 2005
2. Sleijfer S: Bleomycin-induced pneumonitis. Chest 120:617-624, 2001
3. Simpson AB, Paul J, Graham J, et al: Fatal bleomycin pulmonary toxicity in the west of Scotland 1991-1995: a review of patients with germ cell tumours. Br J Cancer 78:1061-1066, 1998
4. Sikdar T, Macvicar D, Husband JE: Pneumomediastinum complicating bleomycin related lung damage. British J Rad 71:1202-1204, 1998
5. Doll DC: Fatal pneumothorax associated with bieomycin-induced pulmonary fibrosis. Cancer Chemother Pharmacol 17:294-295, 1986
6. White DA, Stover DE: Severe bieomycin-induced pneumonitis, clinical features and response to corticosteroids. Chest 86:723-728, 1984
7. O'Sullivan JM, Huddart RA, Norman AR, et al: Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol 14:91-96, 2003
8. McKeage MJ, Evans BD, Atkinson C, et al: Carbon monoxide diffusing capacity is a poor predictor of clinically significant bleomycin lung. J Clin Oncol 8:765-767, 1990
9. Sorensen PF, Rossing N, Rorth M: Carbon monoxide diffusing capacity: A reliable indicator of bieomycin-induced pulmonary toxicity. Eur J Respir Dis 66:333-340, 1985
10. Lucraft HH, Wilkinson PM, Stretton TB, et al: Role of pulmonary function tests in prevention of bleomycin pulmonary toxicity during chemotherapy for metastatic testicular teratoma. Eur J Cancer Clin Oncol 18:133-139, 1982